- Home
- VOYA vs HALO Comparison
VOYA vs HALO Comparison
Compare VOYA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VOYA | HALO |
|---|---|---|
| Founded | 1975 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.8B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | VOYA | HALO |
|---|---|---|
| Price | $66.25 | $63.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $85.90 | $78.18 |
| AVG Volume (30 Days) | 922.5K | ★ 1.8M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.56 |
| Revenue | N/A | ★ $151,862,000.00 |
| Revenue This Year | $4.27 | $28.24 |
| Revenue Next Year | $4.98 | $12.79 |
| P/E Ratio | ★ $12.00 | $24.83 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $52.43 | $47.50 |
| 52 Week High | $79.99 | $82.22 |
Technical Indicators
Market Signals| Indicator | VOYA | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 38.67 | 28.72 |
| Support Level | $66.17 | $61.23 |
| Resistance Level | $76.11 | $65.40 |
| Average True Range (ATR) | 2.53 | 1.87 |
| MACD | -0.24 | -0.73 |
| Stochastic Oscillator | 23.42 | 5.17 |
Price Performance
Historical ComparisonAbout VOYA Voya Financial Inc.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.